A few days ago, my company hunan kangpu pharmaceutical Co., LTD. To reach an agreement, the general the company product was Syria sola piece, the products are expected to formally put into production July on sales.

Solana of Syria was of proton pump inhibitors (PPI), the gastric duodenal ulcer stomach trouble is of special curative effect. Compared with prilosec, Syria was strong acid or relieving effect 2-10 times, the living creature exploitation degree is higher, a faster onset, more significant side effects, more effect of small. At the same time, he was as a new of clinical eradicate h. pylori (HP) treatment is the first choice. Used in the treatment of gastric ulcer, duodenal ulcer, the flowing esophagitis, adjuvant-ai (Zollinger-Ellison) syndrome.

PPI preparations in our ry medicine market stomach overwhelmingly market position. Aram was new as the latest generation of PPI ? system